Evidence map›Paper›PMID 41674789›Full record

ArticleFrontiers in pediatrics2025

C3 molecular structural and histopathological analyses in a pediatric case of atypical hemolytic uremic syndrome with life-threatening gastrointestinal bleeding-a case report.

Takuji Enya, Kohei Miyazaki, Sakina Kuge, Yuichi Morimoto, Hiroki Kondou, Naoki Sakata, Kensuke Joh, China Nagano, Kandai Nozu, Nobutoshi Ito and 3 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Takuji EnyaDepartment of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan.
Kohei MiyazakiDepartment of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan.
Sakina KugeDepartment of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan.
Yuichi MorimotoDepartment of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan.
Hiroki KondouDepartment of Pediatrics, Kindai University Nara Hospital, Nara, Japan.
Naoki SakataDepartment of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan.
Kensuke JohDepartment of Pathology, Jikei University Hospital, Tokyo, Japan.
China NaganoDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Kandai NozuDepartment of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Nobutoshi ItoMedical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
Yoshiyuki HakataDepartment of Immunology, Kindai University Faculty of Medicine, Osaka, Japan.
Keisuke SugimotoDepartment of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan.
Masaaki MiyazawaDepartment of Immunology, Kindai University Faculty of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease characterized by uncontrolled complement activation and is associated with various genetic factors, including multiple variants at the gene locus encoding the complement component 3 (C3). However, only a few functional amino acid substitutions have been identified in C3. We report a pediatric case of aHUS presenting with refractory hypertension and massive gastrointestinal bleeding. Comprehensive histopathological, immunohistochemical, genetic, and molecular structural analyses were performed. Biopsy specimens were stained for renin and the membrane-attack complex of the complement system (C5b-9). Plasma levels of the Ba fragment of complement factor B were measured to evaluate the alternative pathway activation. Genomic DNA was obtained with consent and analyzed by targeted next-generation sequencing using a custom gene panel, followed by Sanger sequencing for variant confirmation. The possible effects of the identified amino acid substitution on the molecular structure of C3 were analyzed using computer-aided simulation with MODELLER and DoGSiteScorer. As a result, the juxtaglomerular apparatus was hyperplastic and intensely stained for renin. Endothelial cells of renal and intestinal blood vessels were positive for C5b-9. The plasma Ba level was elevated compared to the control level. The ileal and colonic mucosae were denuded and highly edematous, with epithelial cells undergoing regenerative and metaplastic changes in the active phase. Mucosal blood vessels contained intraluminal red cell fragments and neutrophils attached to swollen endothelial cells. However, the colonic mucosa showed near-normal histology after disease convalescence. Genetic analyses identified a single nucleotide C3 variant NM_000064.4(C3):c.4811T>C (p.Met1604Thr), resulting in an M

Indexed as

atypical hemolytic uremic syndromeC345C domainC3 variantgastrointestinal bleedingrefractory hypertension

Identifiers

PMID41674789
PMCPMC12886399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.